As one would expect for a gracefully aging institution, the aesthetic of Willamette Week has evolved over the ...

Curevac N.V. ( (CVAC) ) has released its Q3 earnings. Here is a breakdown of the information Curevac N.V. presented to its investors. CureVac ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

With the rise of social media marketing and the number of channels new businesses must create for, a logo is often the first asset a solopreneur needs. Picsart has built an easy-to-use, free, and fun ...

Cash and cash equivalents amounted to EUR 550.9 million at the end of September 2024, increasing from EUR 402.5 million at the end of 2023. The ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

ii This approval underscores GSK's commitment to help drive progress for people living with complex blood cancers.

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...